Cargando…
Molecular landscape in acute myeloid leukemia: where do we stand in 2016
Acute myeloid leukemia (AML) is a clonal disorder characterized by the accumulation of complex genomic alterations that define the disease pathophysiology and overall outcome. Recent advances in sequencing technologies have described the molecular landscape of AML and identified several somatic alte...
Autores principales: | Al-Issa, Karam, Nazha, Aziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250605/ https://www.ncbi.nlm.nih.gov/pubmed/28154779 http://dx.doi.org/10.20892/j.issn.2095-3941.2016.0061 |
Ejemplares similares
-
Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?
por: Barbullushi, Kordelia, et al.
Publicado: (2022) -
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021) -
Recent advances in understanding chronic myeloid leukemia: where do we stand?
por: Kumar, Rahul, et al.
Publicado: (2021) -
Where Do We Stand?
Publicado: (1891) -
Translating tolerogenic therapies to the clinic – where do we stand?
por: Issa, Fadi, et al.
Publicado: (2012)